Related Experiment Video
Updated: Jul 1, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Current update of short-bowel syndrome
1Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA. scolapio.james@mayo.edu
Purpose Of Review:
The purpose of this article is to review the current data on trophic factors in adult patients with short-bowel syndrome. The present article reviews the clinical role of glutamine, growth hormone, and GLP-2 in the treatment of short-bowel syndrome.
Recent Findings:
This review is clinically relevant, given the recent publications in this area. The summary of the current literature does not support that the currently available trophic factors are clinically beneficial for patients with short-bowel syndrome.
Summary:
Systemic side effects from growth hormone factors have been reported. Current trophic should be considered investigational and not standard of practice in the author's opinion.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome

